The Appropriate Allocation of CEUS in the Diagnostic Algorithm of Liver Lesions: A Debated Issue

Ultrasound in Medicine and Biology

Volumn 39, Issue 2, 2013, Pages 183-185

  Bolondi, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM;

ALGORITHM; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE ORGANIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; ULTRASOUND;

EID: 84871805426     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2012.10.001     Document Type: Note

References (24)

1. Albrecht T., Blomley M., Bolondi L., Claudon M., Correas J.M., Cosgrove D., Greiner L., Jäger K., Jong N.D., Leen E., Lencioni R., Lindsell D., Martegani A., Solbiati L., Thorelius L., Tranquart F., Weskott H.P., Whittingham T. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004, 25:249-256. EFSUMB Study Group.
2. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. Practice Guidelines Committee, American Association for the Study of Liver Diseases.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma: An update. Hepatology 2011, 53:1020-1022. American Association for the Study of Liver Diseases.
4. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., Rodés J. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421-430. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma.
5. Bzyl J, Palmowski M, Rix A, Arns S, Hyvelin JM, Pochon S, Ehling J, Schrading S, Kiessling F, Lederle W. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol 2012, (in press). doi:10.1007/s00330-012-2594-z.
6. Claudon M., Cosgrove D., Albrecht T., Bolondi L., Bosio M., Calliada F., Correas J.M., Darge K., Dietrich C., D'Onofrio M., Evans D.H., Filice C., Greiner L., Jäger K., Jong N., Leen E., Lencioni R., Lindsell D., Martegani A., Meairs S., Nolsøe C., Piscaglia F., Ricci P., Seidel G., Skjoldbye B., Solbiati L., Thorelius L., Tranquart F., Weskott H.P., Whittingham T. Guidelines and good clinical recommendations for contrast enhanced ultrasound (CEUS): Update 2008. Ultraschall Med 2008, 29:28-44.
7. Dietrich C.F., Averkiou M.A., Correas J.M., Lassau N., Leen E., Piscaglia F. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med 2012, 33:344-351.
8. DG5 SonoVue (sulphur hexafluoride microbubbles): Contrast agent for contrast-enhanced ultrasound imaging of the liver: Full guidance. 2012; Available at http://www.nice.org.uk/dg5.
9. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012, 56:908-943.
10. Faccioli N., D'Onofrio M., Comai A., Cugini C. Contrast-enhanced ultrasonography in the characterization of benign focal liver lesions: Activity-based cost analysis. Radiol Med 2007, 112:810-820.
11. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K., Maekawa K. Differential diagnosis of hepatic tumors: Value of contrast-enhanced harmonic sonography using the newly developed contrast agent. Sonazoid. Intervirology 2008, 51(suppl 1):61-69.
12. Hohmann J., Muller A., Skrok J., Wolf K.J., Martegani A., Dietrich C.F., Albrecht T. Detection of hepatocellular carcinoma and liver metastases with BR14: A multicenter phase IIA study. Ultrasound Med Biol 2012, 38:377-382.
13. Kudo M., Izumi N., Kokudo N., Matsui O., Sakamoto M., Nakashima O., Kojiro M., Makuuchi M. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011, 29:339-364. HCC Expert Panel of Japan Society of Hepatology.
14. Lassau N., Koscielny S., Chami L., Chebil M., Benatsou B., Roche A., Ducreux M., Malka D., Boige V. Advanced hepatocellular carcinoma: Early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification: Preliminary results. Radiology 2011, 258:291-300.
15. Omata M., Lesmana L.A., Tateishi R., Chen P.J., Lin S.M., Yoshida H., Kudo M., Lee J.M., Choi B.I., Poon R.T., Shiina S., Cheng A.L., Jia J.D., Obi S., Han K.H., Jafri W., Chow P., Lim S.G., Chawla Y.K., Budihusodo U., Gani R.A., Lesmana C.R., Putranto T.A., Liaw Y.F., Sarin S.K. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010, 4:439-474.
16. Piscaglia F., Leoni S., Cabibbo G., Borghi A., Imbriaco G., Golfieri R., Bolondi L. Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. Dig Liver Dis 2010, 42:729-734.
17. Romanini L., Passamonti M., Aiani L., Cabassa P., Raieli G., Montermini I., Martegani A., Grazioli L., Calliada F. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: A multicentre Italian experience. Eur Radiol 2007, 17(suppl 6):F99-F106.
18. Sirli R., Sporea I., Martie A., Popescu A., Danila M. Contrast-enhanced ultrasound in focal liver lesions: A cost-efficiency study. Med Ultrason 2010, 12:280-285.
19. Strobel D, Seitz K, Blank W, Schuler A, Dietrich C., von Herbay A., Friedrich-Rust M., Kunze G., Becker D., Will U., Kratzer W., Albert F.W., Pachmann C., Dirks K., Strunk H., Greis C., Bernatik T Contrast-enhanced ultrasound for the characterization of focal liver lesions: Diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall Med 2008, 29:499-505.
20. Tardy I., Pochon S., Theraulaz M., Emmel P., Passantino L., Tranquart F., Schneider M. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 2010, 45:573-578.
21. Tranquart F., Correas J.M., Ladam Marcus V., Manzoni P., Vilgrain V., Aube C., Elmaleh A., Chami L., Claudon M., Cuilleron M., Diris B., Garibaldi F., Lucidarme O., Marion D., Beziat C., Rode A., Tasu J.P., Trillaud H, Bleuzen A, Le Gouge A., Giraudeau B., Rusch E. Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: Diagnostic efficacy and economical issues from a French multicentric study. J Radiol 2009, 90:109-122.
22. Tranquart F., Mercier L., Frinking P., Gaud E., Arditi M. Perfusion quantification in contrast-enhanced ultrasound (CEUS): Ready for research projects and routine clinical use. Ultraschall Med 2012, 33(suppl 1):S31-S38.
23. Trillaud H., Bruel J.M., Valette P.J., Vilgrain V., Schmutz G., Oyen R., Jakubowski W., Danes J., Valek V., Greis C. Characterization of focal liver lesions with SonoVue-enhanced sonography: International multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009, 15:3748-3756.
24. Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J., de Lope C.R., Reig M., Ayuso C., Brú C., Bruix J. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010, 51:2020-2029.